Published in Rev Neurosci on January 01, 2014
Feedforward and feedback motor control abnormalities implicate cerebellar dysfunctions in autism spectrum disorder. J Neurosci (2015) 0.98
Cellular commitment in the developing cerebellum. Front Cell Neurosci (2015) 0.86
The therapeutic potential of the cerebellum in schizophrenia. Front Syst Neurosci (2014) 0.84
Reversal of neurobehavioral social deficits in dystrophic mice using inhibitors of phosphodiesterases PDE5A and PDE9A. Transl Psychiatry (2016) 0.75
Prenatal drug exposures sensitize noradrenergic circuits to subsequent disruption by chlorpyrifos. Toxicology (2015) 0.75
Spontaneous activity and functional connectivity in the developing cerebellorubral system. J Neurophysiol (2016) 0.75
Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature (2001) 25.15
Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell (1991) 17.00
Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat Genet (2006) 11.14
Genetic architectures of psychiatric disorders: the emerging picture and its implications. Nat Rev Genet (2012) 5.99
Shank3 mutant mice display autistic-like behaviours and striatal dysfunction. Nature (2011) 5.62
Neuroanatomy of autism. Trends Neurosci (2008) 5.59
Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. Am J Psychiatry (2010) 5.27
Association within a family of a balanced autosomal translocation with major mental illness. Lancet (1990) 3.94
Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model. Nat Genet (2008) 3.76
"Cognitive dysmetria" as an integrative theory of schizophrenia: a dysfunction in cortical-subcortical-cerebellar circuitry? Schizophr Bull (1998) 3.67
The behavioral phenotype in fragile X: symptoms of autism in very young children with fragile X syndrome, idiopathic autism, and other developmental disorders. J Dev Behav Pediatr (2001) 3.64
The DISC locus in psychiatric illness. Mol Psychiatry (2007) 3.46
Disrupted in Schizophrenia 1 Interactome: evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia. Mol Psychiatry (2006) 3.33
Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster. Trends Immunol (2002) 3.24
Autistic-like behaviour and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice. Nature (2012) 3.12
An emerging concept. The cerebellar contribution to higher function. Arch Neurol (1991) 3.11
Neuroanatomic observations of the brain in autism: a review and future directions. Int J Dev Neurosci (2005) 3.01
Linking neurodevelopmental and synaptic theories of mental illness through DISC1. Nat Rev Neurosci (2011) 2.89
Deletion of FMR1 in Purkinje cells enhances parallel fiber LTD, enlarges spines, and attenuates cerebellar eyelid conditioning in Fragile X syndrome. Neuron (2005) 2.82
Altered ultrasonic vocalization in mice with a disruption in the Foxp2 gene. Proc Natl Acad Sci U S A (2005) 2.76
ProSAP/Shank proteins - a family of higher order organizing molecules of the postsynaptic density with an emerging role in human neurological disease. J Neurochem (2002) 2.71
FOXP2 as a molecular window into speech and language. Trends Genet (2009) 2.59
Disruption of the nuclear hormone receptor RORalpha in staggerer mice. Nature (1996) 2.58
Detection of serum antibodies to Borna disease virus in patients with psychiatric disorders. Science (1985) 2.57
Identification of a recurrent breakpoint within the SHANK3 gene in the 22q13.3 deletion syndrome. J Med Genet (2005) 2.54
The inferior parietal lobule is the target of output from the superior colliculus, hippocampus, and cerebellum. J Neurosci (2001) 2.43
Schizophrenia and cognitive dysmetria: a positron-emission tomography study of dysfunctional prefrontal-thalamic-cerebellar circuitry. Proc Natl Acad Sci U S A (1996) 2.40
The role of the cerebellum in schizophrenia. Biol Psychiatry (2008) 2.39
Neuropathological findings in autism. Brain (2004) 2.34
Consensus paper: pathological role of the cerebellum in autism. Cerebellum (2012) 2.32
Effects of prenatal infection on brain development and behavior: a review of findings from animal models. Brain Behav Immun (2010) 2.19
Neuropathology of infantile autism. J Neuropathol Exp Neurol (1998) 2.04
Infectious agents associated with schizophrenia: a meta-analysis. Schizophr Res (2011) 1.98
Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism. Neuropsychopharmacology (2005) 1.94
Neurodevelopmental model of schizophrenia: update 2012. Mol Psychiatry (2012) 1.91
Genomic structure and localisation within a linkage hotspot of Disrupted In Schizophrenia 1, a gene disrupted by a translocation segregating with schizophrenia. Mol Psychiatry (2001) 1.81
In-vivo rodent models for the experimental investigation of prenatal immune activation effects in neurodevelopmental brain disorders. Neurosci Biobehav Rev (2009) 1.74
Abnormal fear conditioning and amygdala processing in an animal model of autism. Neuropsychopharmacology (2007) 1.73
Activation of the maternal immune system alters cerebellar development in the offspring. Brain Behav Immun (2008) 1.67
Modeling autism by SHANK gene mutations in mice. Neuron (2013) 1.64
Basal ganglia and cerebellar inputs to 'AIP'. Cereb Cortex (2004) 1.61
Gabrb3 gene deficient mice exhibit impaired social and exploratory behaviors, deficits in non-selective attention and hypoplasia of cerebellar vermal lobules: a potential model of autism spectrum disorder. Behav Brain Res (2007) 1.58
Behavioral profiles of mouse models for autism spectrum disorders. Autism Res (2011) 1.57
Effects of enriched environment on animal models of neurodegenerative diseases and psychiatric disorders. Neurobiol Dis (2008) 1.55
Does the cerebellum contribute to mental skills? Behav Neurosci (1986) 1.54
Expression of disrupted in schizophrenia 1 (DISC1) protein in the adult and developing mouse brain indicates its role in neurodevelopment. Mol Psychiatry (2004) 1.51
Abnormal embryonic cerebellar development and patterning of postnatal foliation in two mouse Engrailed-2 mutants. Development (1994) 1.51
Expression of Disrupted-In-Schizophrenia-1, a schizophrenia-associated gene, is prominent in the mouse hippocampus throughout brain development. Neuroscience (2004) 1.48
Review of pathological hallmarks of schizophrenia: comparison of genetic models with patients and nongenetic models. Schizophr Bull (2009) 1.44
Maternal infection leads to abnormal gene regulation and brain atrophy in mouse offspring: implications for genesis of neurodevelopmental disorders. Schizophr Res (2008) 1.42
Genetics of schizophrenia: new findings and challenges. Annu Rev Genomics Hum Genet (2011) 1.41
The viral mimic, polyinosinic:polycytidylic acid, induces fever in rats via an interleukin-1-dependent mechanism. Am J Physiol Regul Integr Comp Physiol (2004) 1.38
Prenatal exposure of rats to valproic acid reproduces the cerebellar anomalies associated with autism. Neurotoxicol Teratol (2000) 1.37
Is the cerebellum relevant in the circuitry of neuropsychiatric disorders? J Psychiatry Neurosci (2005) 1.35
Linking etiologies in humans and animal models: studies of autism. Reprod Toxicol (1997) 1.34
Genetic advances in the study of speech and language disorders. Neuron (2010) 1.33
En2 knockout mice display neurobehavioral and neurochemical alterations relevant to autism spectrum disorder. Brain Res (2006) 1.28
Normal female sexual development requires neuregulin-erbB receptor signaling in hypothalamic astrocytes. J Neurosci (2003) 1.28
In utero exposure to valproic acid and autism--a current review of clinical and animal studies. Neurotoxicol Teratol (2013) 1.25
Environmental enrichment reverses behavioral alterations in rats prenatally exposed to valproic acid: issues for a therapeutic approach in autism. Neuropsychopharmacology (2006) 1.22
Cloning and characterization of Disc1, the mouse ortholog of DISC1 (Disrupted-in-Schizophrenia 1). Genomics (2002) 1.22
Autism-relevant social abnormalities and cognitive deficits in engrailed-2 knockout mice. PLoS One (2012) 1.21
Motor mechanisms of the CNS: cerebrocerebellar interrelations. Annu Rev Physiol (1969) 1.21
Cytokine dysregulation in autism spectrum disorders (ASD): possible role of the environment. Neurotoxicol Teratol (2012) 1.21
Borna disease virus and schizophrenia. Psychiatry Res (1995) 1.19
Evidence implicating the candidate schizophrenia/bipolar disorder susceptibility gene G72 in mitochondrial function. Mol Psychiatry (2007) 1.18
Neuroimaging of autism. Neuroradiology (2009) 1.17
Allelic association of G72/G30 with schizophrenia and bipolar disorder: a comprehensive meta-analysis. Schizophr Res (2007) 1.16
Pattern deformities and cell loss in Engrailed-2 mutant mice suggest two separate patterning events during cerebellar development. J Neurosci (1997) 1.15
Pathogenic disruption of DISC1-serine racemase binding elicits schizophrenia-like behavior via D-serine depletion. Mol Psychiatry (2012) 1.15
Anatomical phenotyping in a mouse model of fragile X syndrome with magnetic resonance imaging. Neuroimage (2010) 1.14
Neuropsychiatric symptoms of fragile X syndrome: pathophysiology and pharmacotherapy. CNS Drugs (2004) 1.14
The genetic architecture of schizophrenia: new mutations and emerging paradigms. Annu Rev Med (2011) 1.14
Questions about DISC1 as a genetic risk factor for schizophrenia. Mol Psychiatry (2013) 1.14
Gender-specific behavioral and immunological alterations in an animal model of autism induced by prenatal exposure to valproic acid. Psychoneuroendocrinology (2008) 1.14
Borna disease virus infection of the neonatal rat: developmental brain injury model of autism spectrum disorders. Front Biosci (2002) 1.13
Autism risk factors: genes, environment, and gene-environment interactions. Dialogues Clin Neurosci (2012) 1.13
What does CNTNAP2 reveal about autism spectrum disorder? Trends Mol Med (2012) 1.12
Genetic and cognitive windows into circuit mechanisms of psychiatric disease. Trends Neurosci (2011) 1.10
Purkinje cell death: differences between developmental cell death and neurodegenerative death in mutant mice. Cerebellum (2006) 1.10
The distinct and overlapping phenotypic spectra of FOXP1 and FOXP2 in cognitive disorders. Hum Genet (2012) 1.08
Cerebellar synaptic protein expression in schizophrenia. Neuroscience (2001) 1.08
Engrailed homeobox genes determine the organization of Purkinje cell sagittal stripe gene expression in the adult cerebellum. J Neurosci (2008) 1.08
The axonal chemorepellant semaphorin 3A is increased in the cerebellum in schizophrenia and may contribute to its synaptic pathology. Mol Psychiatry (2003) 1.08
Evidence of reactive astrocytes but not peripheral immune system activation in a mouse model of Fragile X syndrome. Biochim Biophys Acta (2010) 1.06
Staggerer chimeras: intrinsic nature of Purkinje cell defects and implications for normal cerebellar development. Brain Res (1979) 1.06
Retinoid-related orphan receptor alpha controls the early steps of Purkinje cell dendritic differentiation. J Neurosci (2006) 1.06
Electron microscopic analysis of postnatal histogenesis in the cerebellar cortex of staggerer mutant mice. J Comp Neurol (1978) 1.05
Loss of Tsc2 in Purkinje cells is associated with autistic-like behavior in a mouse model of tuberous sclerosis complex. Neurobiol Dis (2012) 1.05
D-amino acid oxidase activity and expression are increased in schizophrenia. Mol Psychiatry (2008) 1.04
The GABA(A) receptor agonist THIP ameliorates specific behavioral deficits in the mouse model of fragile X syndrome. Dev Neurosci (2011) 1.04
Immune system gene dysregulation in autism and schizophrenia. Dev Neurobiol (2012) 1.04
N-acetyl cysteine treatment rescues cognitive deficits induced by mitochondrial dysfunction in G72/G30 transgenic mice. Neuropsychopharmacology (2011) 1.02
Sex, glia, and development: interactions in health and disease. Horm Behav (2012) 1.01
To poly(I:C) or not to poly(I:C): advancing preclinical schizophrenia research through the use of prenatal immune activation models. Neuropharmacology (2011) 1.01
Neuroglialpharmacology: myelination as a shared mechanism of action of psychotropic treatments. Neuropharmacology (2012) 1.00
DNA methylation regulates tissue-specific expression of Shank3. J Neurochem (2007) 1.00
Loss of the tuberous sclerosis complex protein tuberin causes Purkinje cell degeneration. Neurobiol Dis (2011) 1.00
Genetics of speech and language disorders. Annu Rev Genomics Hum Genet (2011) 0.99
Prenatal interaction of mutant DISC1 and immune activation produces adult psychopathology. Biol Psychiatry (2010) 2.11
Review of pathological hallmarks of schizophrenia: comparison of genetic models with patients and nongenetic models. Schizophr Bull (2009) 1.44
The dynamin-related GTPase Opa1 is required for glucose-stimulated ATP production in pancreatic beta cells. Mol Biol Cell (2011) 1.26
Toxoplasma gondii strain-dependent effects on mouse behaviour. Folia Parasitol (Praha) (2010) 1.19
The AAA+ ATPase Thorase regulates AMPA receptor-dependent synaptic plasticity and behavior. Cell (2011) 1.07
Animal models of gene-environment interactions in schizophrenia. Behav Brain Res (2009) 0.98
Toxoplasma gondii and cognitive deficits in schizophrenia: an animal model perspective. Schizophr Bull (2012) 0.96
Abnormal social behaviors in young and adult rats neonatally infected with Borna disease virus. Behav Brain Res (2006) 0.96
Astrocytes play a key role in activation of microglia by persistent Borna disease virus infection. J Neuroinflammation (2008) 0.93
Mouse models of gene-environment interactions in schizophrenia. Neurobiol Dis (2013) 0.90
DISC1 Pathway in Brain Development: Exploring Therapeutic Targets for Major Psychiatric Disorders. Front Psychiatry (2012) 0.90
Mutant DISC1 affects methamphetamine-induced sensitization and conditioned place preference: a comorbidity model. Neuropharmacology (2011) 0.89
Enhanced neurovirulence of borna disease virus variants associated with nucleotide changes in the glycoprotein and L polymerase genes. J Virol (2002) 0.89
GluA3-deficiency in mice is associated with increased social and aggressive behavior and elevated dopamine in striatum. Behav Brain Res (2012) 0.88
Persistent Borna Disease Virus (BDV) infection activates microglia prior to a detectable loss of granule cells in the hippocampus. J Neuroinflammation (2008) 0.88
18F-ASEM, a radiolabeled antagonist for imaging the α7-nicotinic acetylcholine receptor with PET. J Nucl Med (2014) 0.88
Early minocycline treatment prevents a decrease in striatal dopamine in an SIV model of HIV-associated neurological disease. J Neuroimmune Pharmacol (2011) 0.88
Activation of microglia by borna disease virus infection: in vitro study. J Virol (2006) 0.87
Expression of mutant human DISC1 in mice supports abnormalities in differentiation of oligodendrocytes. Schizophr Res (2011) 0.86
Anti-gluten immune response following Toxoplasma gondii infection in mice. PLoS One (2012) 0.86
Effect of fenbendazole on three behavioral tests in male C57BL/6N mice. J Am Assoc Lab Anim Sci (2010) 0.86
Neuron-glia interactions clarify genetic-environmental links in mental illness. Trends Neurosci (2004) 0.86
Inhibition of glutamate carboxypeptidase II (GCPII) activity as a treatment for cognitive impairment in multiple sclerosis. Proc Natl Acad Sci U S A (2012) 0.85
Elevated testosterone and reduced 5-HIAA concentrations are associated with wounding and hantavirus infection in male Norway rats. Horm Behav (2007) 0.84
Chronic exposure of mutant DISC1 mice to lead produces sex-dependent abnormalities consistent with schizophrenia and related mental disorders: a gene-environment interaction study. Schizophr Bull (2013) 0.83
Neonatal Borna disease virus infection in rats is associated with increased extracellular levels of glutamate and neurodegeneration in the striatum. J Neurovirol (2007) 0.82
Endocannabinoid system: potential novel targets for treatment of schizophrenia. Neurobiol Dis (2012) 0.82
Working memory deficits in neuronal nitric oxide synthase knockout mice: potential impairments in prefrontal cortex mediated cognitive function. Biochem Biophys Res Commun (2011) 0.81
The Toxoplasma MAG1 peptides induce sex-based humoral immune response in mice and distinguish active from chronic human infection. Microbes Infect (2012) 0.80
Frontal cortical synaptic communication is abnormal in Disc1 genetic mouse models of schizophrenia. Schizophr Res (2013) 0.80
Diffusion Tensor Imaging Abnormalities in the Cerebral White Matter Correlate with Sex-Dependent Neurobehavioral Deficits in Adult Mice with Neonatal Ischemia. Dev Neurosci (2016) 0.78
Postnatal weight gain inhibition does not account for neurobehavioral consequences of neonatal Borna disease virus infection. Physiol Behav (2003) 0.76
A Novel Experimental Animal Model of Adult Chronic Hydrocephalus. Neurosurgery (2016) 0.76
Quantitative Multi-modal Brain Autoradiography of Glutamatergic, Dopaminergic, Cannabinoid, and Nicotinic Receptors in Mutant Disrupted-In-Schizophrenia-1 (DISC1) Mice. Mol Imaging Biol (2015) 0.75
The contingent negative variation laterality and dynamics in antisaccade task in normal and unmedicated schizophrenic subjects. Span J Psychol (2011) 0.75